Azmacort and Hyponatraemia aggravated - a phase IV clinical study of FDA data

Summary:

Hyponatraemia aggravated is reported as a side effect among people who take Azmacort (triamcinolone acetonide), especially for people who are female, 60+ old, also take Premarin, and have Osteopenia.

The phase IV clinical study analyzes which people have Hyponatraemia aggravated when taking Azmacort. It is created by eHealthMe based on reports of 3,588 people who have side effects when taking Azmacort from the FDA, and is updated regularly.

What is Azmacort?

Azmacort has active ingredients of triamcinolone acetonide. It is often used in asthma. eHealthMe is studying from 3,612 Azmacort users. Check the latest studies of Azmacort.

What is Hyponatraemia aggravated?

Hyponatraemia aggravated (abnormally low concentrations of sodium ions in the circulating blood) is found to be associated with 1,508 drugs and 543 conditions by eHealthMe. Check the latest studies of Hyponatraemia aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

3,588 people reported to have side effects when taking Azmacort.
Among them, 15 people (0.42%) have Hyponatraemia aggravated.

Could Azmacort cause Hyponatraemia aggravated?

Among these 15 people:

What is the gender of people who have Hyponatraemia aggravated when taking Azmacort? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Hyponatraemia aggravated when taking Azmacort? *

What are other drugs people take besides Azmacort? *

What are other side effects people have besides Hyponatraemia aggravated? *

Nausea (feeling of having an urge to vomit): 6 people, 40.00%
Fall: 4 people, 26.67%
Constipation: 4 people, 26.67%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 4 people, 26.67%
Nausea And Vomiting: 3 people, 20.00%
Osteoporosis (bones weak and more likely to break): 3 people, 20.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 20.00%
Femur Fracture: 3 people, 20.00%
Foot Deformity (functional disability of foot): 3 people, 20.00%
Foot Fracture: 3 people, 20.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 3 people, 20.00%
Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 20.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 13.33%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 6.67%
Multiple Myeloma (cancer of the plasma cells): 1 person, 6.67%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Azmacort and have Hyponatraemia aggravated?

- Check whether Hyponatraemia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azmacort:

Azmacort (3,612 reports)

Browse all side effects of Azmacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyponatraemia aggravated:

Hyponatraemia aggravated (1,508 drugs)

Browse all the conditions that are associated with Hyponatraemia aggravated:

Hyponatraemia aggravated (543 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Azmacort) and Azmacort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.